Markets · 1 sources covering this

Sun Pharma Explores Funding Mix for $12 Billion Organon Deal

Global lenders to Sun Pharmaceutical Industries Ltd. are weighing multiple financing options for its proposed $12 billion acquisition of New York-listed healthcare company Organon & Co., according to people familiar with the matter.

Coverage spectrum

1 L · 0 C · 0 R

How 1 sources are covering this

BloombergLean L·4h ago
Sun Pharma Explores Funding Mix for $12 Billion Organon Deal
Global lenders to Sun Pharmaceutical Industries Ltd. are weighing multiple financing options for its proposed $12 billion acquisition of New York-listed healthcare company Organon & Co., according to people familiar with the matter.
Read at Bloomberg →

Sun Pharma Explores Funding Mix for $12 Billion Organon Deal

How 1 sources are covering this

Sun Pharma Explores Funding Mix for $12 Billion Organon Deal

More from Markets

Lufthansa Reports Narrower Loss, Sees Risks from Fuel Supplies

Ayub: Yo-Yo on Foreign Policy Driving Risk Sentiment

Yen Rallies to Build on Gains Spurred by Recent Intervention

Sany Heavy Is Said to Consider IPO for Electric Unit in Hong Kong

Reader

Trust & legal

Across the network